EPISODE · Apr 19, 2023 · 1H 1M
TechBio Founders #14 : Transforming human antibodies into drugs with Wyatt McDonnell, CEO Infinimmune
from Next Sequence · host Wyatt McDonnell, Loretta TIOIELA
Infinimmune’s founding team are tool builders who design from first principles and have broad expertise across immunology, single cell technologies, protein engineering, computational biology, and genome assembly.Transforming human antibodies into drugs.
Embed this episode
NOW PLAYING
TechBio Founders #14 : Transforming human antibodies into drugs with Wyatt McDonnell, CEO Infinimmune
0:00
1:01:00
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of Next Sequence?
This episode is 1 hour and 1 minute long.
When was this Next Sequence episode published?
This episode was published on April 19, 2023.
Can I download this Next Sequence episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!